Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Bio-Thera Solutions stock

688177.SS
CNE100003R98

Price

21.26
Today +/-
-0.12
Today %
-4.15 %
P

Bio-Thera Solutions stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Bio-Thera Solutions stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Bio-Thera Solutions stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Bio-Thera Solutions stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Bio-Thera Solutions's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Bio-Thera Solutions Stock Price History

DateBio-Thera Solutions Price
11/18/202421.26 undefined
11/15/202422.16 undefined
11/14/202423.09 undefined
11/13/202423.75 undefined
11/12/202424.20 undefined
11/11/202424.56 undefined
11/8/202424.14 undefined
11/7/202424.09 undefined
11/6/202423.30 undefined
11/5/202423.60 undefined
11/4/202422.93 undefined
11/1/202422.54 undefined
10/31/202423.15 undefined
10/30/202423.10 undefined
10/29/202424.17 undefined
10/28/202425.11 undefined
10/25/202424.22 undefined
10/24/202423.28 undefined
10/23/202423.34 undefined
10/22/202423.07 undefined
10/21/202422.86 undefined

Bio-Thera Solutions Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Bio-Thera Solutions, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Bio-Thera Solutions from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Bio-Thera Solutions’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Bio-Thera Solutions. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Bio-Thera Solutions’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Bio-Thera Solutions’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Bio-Thera Solutions’s growth potential.

Bio-Thera Solutions Revenue, EBIT and net profit per share

DateBio-Thera Solutions RevenueBio-Thera Solutions EBITBio-Thera Solutions Net Income
2026e4.46 B undefined1.76 B undefined1.49 B undefined
2025e1.3 B undefined-147.46 M undefined-146.38 M undefined
2024e1.04 B undefined-274.72 M undefined-276.03 M undefined
2023704.79 M undefined-394.44 M undefined-394.53 M undefined
2022455.13 M undefined-494.66 M undefined-480.4 M undefined
2021836.58 M undefined96.44 M undefined81.94 M undefined
2020185 M undefined-524.9 M undefined-513.2 M undefined
2019700,000 undefined-1.02 B undefined-1.02 B undefined
20180 undefined-553.3 M undefined-553.1 M undefined
20172 M undefined-239.7 M undefined-235.5 M undefined
20162.8 M undefined-142.8 M undefined-136.6 M undefined

Bio-Thera Solutions Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201620172018201920202021202220232024e2025e2026e
00000.190.840.460.71.041.34.46
-----351.89-45.5754.7347.0225.80242.86
25,500.0050.00--89.1995.6958.0272.4449.2839.1711.42
0100165800264510000
-0.14-0.24-0.55-1.02-0.510.08-0.48-0.39-0.28-0.151.49
-72.79135.3284.81-49.80-115.79-692.59-17.92-29.95-47.10-1,120.55
105.3105.3121.5345.5404.1414.08414.08414.08000
-----------
Details

Keystats

ⓘ

Revenue and Growth

The Bio-Thera Solutions Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Bio-Thera Solutions is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
20162017201820192020202120222023
               
0.320.030.10.031.231.440.780.45
000055.4103.3289.75148.72
000056.952.0724.0362.24
2.17.936.743.645.990.1161.9231.23
11.268.580.881.283.588.75111.28119.37
0.330.110.220.151.471.771.161.01
0.330.430.440.470.590.590.781.01
000000010
1841.287.9100.571.6000
23.523253.2248.6245.4239.47234.18230.38
00000000
0020.320.520.821.1021.87
0.380.50.80.840.930.851.021.28
0.710.611.020.992.392.622.182.29
               
105.3105.3121.5354.1414.1414.08414.08414.08
0.690.741.731.233.053.053.053.05
-264.1-499.6-1,052.7-949.5-1,462.8-1,380.82-1,861.22-2,255.75
0000-100-128.6813.184.81
00000000
0.530.350.80.632.012.091.611.21
116.2111.499.1153.584.845.6983.77171.45
6.411.72223.333.548.1151.8353.94
50.780.892101.9263.4396.56396.05340.23
0670101.83.733.33.36106.4
000002.383.4953.39
173.3270.9213.1380.5385.4526.04538.5725.42
0000006.01323.84
00000000
0.50.46.23.22.24.2327.9725.13
0.50.46.23.22.24.2333.98348.97
0.170.270.220.380.390.530.571.07
0.710.621.021.012.392.622.182.29
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Bio-Thera Solutions provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Bio-Thera Solutions's financial health and stability.

Assets

Bio-Thera Solutions's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Bio-Thera Solutions must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Bio-Thera Solutions after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Bio-Thera Solutions's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2016201720182019202020212022
0000000
0000000
0000000
-137-238-559-595-675-787-867
0000000
0000000
0031-1252434
-116-236-528-598-358236-412
-119-160-317-74-253-77-258
-119-145-339-74-1,177301-245
015-210-92437913
0000000
000101-10130-27
0000000
0.550.10.930.61.780.03-0.03
0.550.10.930.51.89-0-0
0000-300
0.33-0.280.07-0.070.541.56-0.27
-235.4-397.5-846-672.8-611.3158.38-671.64
0000000

Bio-Thera Solutions stock margins

The Bio-Thera Solutions margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Bio-Thera Solutions. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Bio-Thera Solutions.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Bio-Thera Solutions's sales revenue. A higher gross margin percentage indicates that the Bio-Thera Solutions retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Bio-Thera Solutions's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Bio-Thera Solutions's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Bio-Thera Solutions's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Bio-Thera Solutions. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Bio-Thera Solutions's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Bio-Thera Solutions Margin History

Bio-Thera Solutions Gross marginBio-Thera Solutions Profit marginBio-Thera Solutions EBIT marginBio-Thera Solutions Profit margin
2026e72.38 %39.38 %33.39 %
2025e72.38 %-11.33 %-11.24 %
2024e72.38 %-26.54 %-26.67 %
202372.38 %-55.96 %-55.98 %
202258.01 %-108.68 %-105.55 %
202195.71 %11.53 %9.79 %
202089.24 %-283.73 %-277.41 %
201985.71 %-145,171.44 %-146,085.72 %
201872.38 %0 %0 %
201765 %-11,985 %-11,775 %
201628.57 %-5,100 %-4,878.57 %

Bio-Thera Solutions Stock Sales Revenue, EBIT, Earnings per Share

The Bio-Thera Solutions earnings per share therefore indicates how much revenue Bio-Thera Solutions has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Bio-Thera Solutions earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Bio-Thera Solutions's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Bio-Thera Solutions’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Bio-Thera Solutions's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Bio-Thera Solutions Revenue, EBIT and net profit per share

DateBio-Thera Solutions Sales per ShareBio-Thera Solutions EBIT per shareBio-Thera Solutions Earnings per Share
2026e10.78 undefined0 undefined3.6 undefined
2025e3.14 undefined0 undefined-0.35 undefined
2024e2.5 undefined0 undefined-0.67 undefined
20231.7 undefined-0.95 undefined-0.95 undefined
20221.1 undefined-1.19 undefined-1.16 undefined
20212.02 undefined0.23 undefined0.2 undefined
20200.46 undefined-1.3 undefined-1.27 undefined
20190 undefined-2.94 undefined-2.96 undefined
20180 undefined-4.55 undefined-4.55 undefined
20170.02 undefined-2.28 undefined-2.24 undefined
20160.03 undefined-1.36 undefined-1.3 undefined

Bio-Thera Solutions business model

Bio-Thera Solutions is one of the most popular companies on Eulerpool.com.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Bio-Thera Solutions Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Bio-Thera Solutions historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Bio-Thera Solutions shares outstanding

The number of shares was Bio-Thera Solutions in 2023 — This indicates how many shares 414.08 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Bio-Thera Solutions earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Bio-Thera Solutions's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Bio-Thera Solutions’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Bio-Thera Solutions's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Bio-Thera Solutions.

Bio-Thera Solutions shareholders

%
Name
Stocks
Change
Date
38.63753 % Guangzhou Hedy Group Co., Ltd.159,990,27006/30/2024
11.39339 % Therabio International Limited47,177,72906/30/2024
5.59634 % Guangzhou Qi Aoxing Investment Partnership Enterprise (LP)23,173,32606/30/2024
5.15198 % Guangzhou Zhongke Yuechuang Incubator Investment Management Co., Ltd.21,333,33206/30/2024
4.82801 % Dongtai Qiheng Pharmaceutical Partnership (L.P.)19,991,83906/30/2024
3.86399 % Guangzhou Shengyu Investment Partnership (LP)16,000,00006/30/2024
2.84003 % Yi (Liangyu)11,760,00206/30/2024
1.77178 % Guangzhou Fanwanhu Investment Partnership (LP)7,336,586-88,0006/30/2024
1.57393 % Li (Sheng Feng)6,517,33206/30/2024
1.10146 % Huitianze Investment Company Ltd.4,560,93106/30/2024
1
2
3
4
5
...
10

Bio-Thera Solutions Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Biogen Stock
Biogen
SupplierCustomer0,480,770,410,700,550,16
Shanghai Medicilon A Stock
Shanghai Medicilon A
SupplierCustomer0,31-0,090,460,580,77-0,60
Cipla Stock
Cipla
SupplierCustomer-0,380,360,36-0,46-0,29-0,82
BeiGene Stock
BeiGene
SupplierCustomer-0,600,550,760,850,81-0,21
1

Most common questions regarding Bio-Thera Solutions

What is the P/E ratio of Bio-Thera Solutions 2024?

The Bio-Thera Solutions P/E ratio is -31.89.

What is the P/S ratio of Bio-Thera Solutions 2024?

The Bio-Thera Solutions P/S ratio is 8.51.

What is the Quality Investing of Bio-Thera Solutions?

The Quality Investing for Bio-Thera Solutions is 3/10.

What is the revenue of Bio-Thera Solutions 2024?

The expected Bio-Thera Solutions revenue is 1.04 B CNY.

How high is the profit of Bio-Thera Solutions 2024?

The expected Bio-Thera Solutions profit is -276.03 M CNY.

What is the business model of Bio-Thera Solutions

No history available for Bio-Thera Solutions.

What is the Bio-Thera Solutions dividend?

Bio-Thera Solutions pays a dividend of 0 CNY distributed over payouts per year.

How often does Bio-Thera Solutions pay dividends?

The dividend cannot currently be calculated for Bio-Thera Solutions or the company does not pay out a dividend.

What is the Bio-Thera Solutions ISIN?

The ISIN of Bio-Thera Solutions is CNE100003R98.

What is the Bio-Thera Solutions ticker?

The ticker of Bio-Thera Solutions is 688177.SS.

How much dividend does Bio-Thera Solutions pay?

Over the past 12 months, Bio-Thera Solutions paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bio-Thera Solutions is expected to pay a dividend of 0 CNY.

What is the dividend yield of Bio-Thera Solutions?

The current dividend yield of Bio-Thera Solutions is .

When does Bio-Thera Solutions pay dividends?

Bio-Thera Solutions pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bio-Thera Solutions?

Bio-Thera Solutions paid dividends every year for the past 0 years.

What is the dividend of Bio-Thera Solutions?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bio-Thera Solutions located?

Bio-Thera Solutions is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bio-Thera Solutions kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bio-Thera Solutions from 11/19/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did Bio-Thera Solutions pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of Bio-Thera Solutions in the year 2023?

In the year 2023, Bio-Thera Solutions distributed 0 CNY as dividends.

In which currency does Bio-Thera Solutions pay out the dividend?

The dividends of Bio-Thera Solutions are distributed in CNY.

All fundamentals about Bio-Thera Solutions

Our stock analysis for Bio-Thera Solutions Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bio-Thera Solutions Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.